OBJECTIVES: To describe facility-level variation in two measures of potentially inappropriate prescribing prevalent in Veterans Affairs (VA) facilities-exposure to high-risk medications in elderly adults (HRME) and drug-disease interactions (Rx-DIS)-and to identify facility characteristics associated with high-quality prescribing. DESIGN: Cross-sectional. SETTING: VA Healthcare System. PARTICIPANTS: Veterans aged 65 and older with at least one inpatient or outpatient visit in 2005-2006 (N = 2,023,477; HRME exposure) and a subsample with a history of falls or hip fractures, dementia, or chronic renal failure (n = 305,059; Rx-DIS exposure). MEASUREMENTS: Incident use of any HRME (iHRME) and incident Rx-DIS (iRx-DIS) and facility-level rates and facility-level predictors of iHRME and iRx-DIS exposure, adjusting for differences in patient characteristics. RESULTS: Overall, 94,692 (4.7%) veterans had iHRME exposure. At the facility level, iHRME exposure ranged from 1.6% at the lowest facility to 12.8% at the highest (median 4.7%). In the subsample, 9,803 (3.2%) veterans had iRx-DIS exposure, with a facility-level range from 1.3% to 5.8% (median 3.2%). In adjusted analyses, veterans seen in facilities with formal geriatric education had lower odds of iHRME (odds ratio (OR) = 0.86, 95% confidence interval (CI) = 0.77-0.96) and iRx-DIS (OR = 0.95, 95% CI = 0.88-1.01). Patients seen in facilities caring for fewer older veterans had greater odds of iHRME (OR = 1.54, 95% CI = 1.35-1.75) and iRx-DIS exposure (OR = 1.22, 95% CI = 1.11-1.33). CONCLUSION: Substantial variation in the quality of prescribing for older adults exists across VA facilities, even after adjusting for patient characteristics. Higher-quality prescribing is found in facilities caring for a larger number of older veterans and facilities with formal geriatric education.
OBJECTIVES: To describe facility-level variation in two measures of potentially inappropriate prescribing prevalent in Veterans Affairs (VA) facilities-exposure to high-risk medications in elderly adults (HRME) and drug-disease interactions (Rx-DIS)-and to identify facility characteristics associated with high-quality prescribing. DESIGN: Cross-sectional. SETTING: VA Healthcare System. PARTICIPANTS: Veterans aged 65 and older with at least one inpatient or outpatient visit in 2005-2006 (N = 2,023,477; HRME exposure) and a subsample with a history of falls or hip fractures, dementia, or chronic renal failure (n = 305,059; Rx-DIS exposure). MEASUREMENTS: Incident use of any HRME (iHRME) and incident Rx-DIS (iRx-DIS) and facility-level rates and facility-level predictors of iHRME and iRx-DIS exposure, adjusting for differences in patient characteristics. RESULTS: Overall, 94,692 (4.7%) veterans had iHRME exposure. At the facility level, iHRME exposure ranged from 1.6% at the lowest facility to 12.8% at the highest (median 4.7%). In the subsample, 9,803 (3.2%) veterans had iRx-DIS exposure, with a facility-level range from 1.3% to 5.8% (median 3.2%). In adjusted analyses, veterans seen in facilities with formal geriatric education had lower odds of iHRME (odds ratio (OR) = 0.86, 95% confidence interval (CI) = 0.77-0.96) and iRx-DIS (OR = 0.95, 95% CI = 0.88-1.01). Patients seen in facilities caring for fewer older veterans had greater odds of iHRME (OR = 1.54, 95% CI = 1.35-1.75) and iRx-DIS exposure (OR = 1.22, 95% CI = 1.11-1.33). CONCLUSION: Substantial variation in the quality of prescribing for older adults exists across VA facilities, even after adjusting for patient characteristics. Higher-quality prescribing is found in facilities caring for a larger number of older veterans and facilities with formal geriatric education.
Authors: Alfredo J Selim; Lewis E Kazis; William Rogers; Shirley Qian; James A Rothendler; Austin Lee; Xinhua S Ren; Samuel C Haffer; Russ Mardon; Donald Miller; Avron Spiro; Bernardo J Selim; Benjamin G Fincke Journal: Med Care Date: 2006-04 Impact factor: 2.983
Authors: Mary Jo V Pugh; Amy K Rosen; Maria Montez-Rath; Megan E Amuan; Benjamin G Fincke; Muriel Burk; Arlene Bierman; Francesca Cunningham; Eric M Mortensen; Dan R Berlowitz Journal: Med Care Date: 2008-02 Impact factor: 2.983
Authors: Alfredo J Selim; Graeme Fincke; Xinhua S Ren; Austin Lee; William H Rogers; Donald R Miller; Katherine M Skinner; Mark Linzer; Lewis E Kazis Journal: J Ambul Care Manage Date: 2004 Jul-Sep
Authors: Elizabeth A Chrischilles; Rachel VanGilder; Kara Wright; Michael Kelly; Robert B Wallace Journal: J Am Geriatr Soc Date: 2009-06 Impact factor: 5.562
Authors: J Michael McWilliams; Jesse B Dalton; Mary Beth Landrum; Austin B Frakt; Steven D Pizer; Nancy L Keating Journal: Ann Intern Med Date: 2014-12-02 Impact factor: 25.391
Authors: Nikki R Wooten; Abbas S Tavakoli; Marlene B Al-Barwani; Naomi A Thomas; Hrishikesh Chakraborty; Anna M Scheyett; Kelly M Kaminski; Alyssia C Woods; Sue E Levkoff Journal: Am J Drug Alcohol Abuse Date: 2017-04-14 Impact factor: 3.829
Authors: Holly M Holmes; Ruili Luo; Yong-Fang Kuo; Jacques Baillargeon; James S Goodwin Journal: Pharmacoepidemiol Drug Saf Date: 2013-03-14 Impact factor: 2.890
Authors: Michael A Steinman; Yinghui Miao; W John Boscardin; Kiya D R Komaiko; Janice B Schwartz Journal: J Gen Intern Med Date: 2014-07-08 Impact factor: 5.128
Authors: Guneet K Jasuja; Shalender Bhasin; Adam J Rose; Joel I Reisman; Joseph T Hanlon; Donald R Miller; Anthony P Morreale; Leonard M Pogach; Francesca E Cunningham; Angela Park; Renda S Wiener; Allen L Gifford; Dan R Berlowitz Journal: J Clin Endocrinol Metab Date: 2017-09-01 Impact factor: 6.134
Authors: Katharina Schmidt-Mende; Morten Andersen; Björn Wettermark; Jan Hasselström Journal: Scand J Prim Health Care Date: 2020-07-29 Impact factor: 2.581